カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のアンチベニン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Antivenin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19155）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19155
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：105
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のアンチベニン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

アンチベニン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のアンチベニンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

アンチベニン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・多価、一価

用途別セグメントは次のように区分されます。
・病院・診療所、非営利団体

世界のアンチベニン市場の主要な市場プレーヤーは以下のとおりです。
・CSL、Merck、BTG、Pfizer、Haffkine Bio-Pharmaceutical、Rare Disease Therapeutics、Flynn Pharma、Vins Bioproducts、Bharat Serums and Vaccines、Serum Biotech、MicroPharm、CSL

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、アンチベニン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なアンチベニンメーカーの企業概要、2019年～2022年までのアンチベニンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なアンチベニンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別アンチベニンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのアンチベニンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのアンチベニン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびアンチベニンの産業チェーンを掲載しています。
・第13、14、15章では、アンチベニンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- アンチベニンの概要
- 種類別分析（2017年vs2021年vs2028年）：多価、一価
- 用途別分析（2017年vs2021年vs2028年）：病院・診療所、非営利団体
- 世界のアンチベニン市場規模・予測
- 世界のアンチベニン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- CSL、Merck、BTG、Pfizer、Haffkine Bio-Pharmaceutical、Rare Disease Therapeutics、Flynn Pharma、Vins Bioproducts、Bharat Serums and Vaccines、Serum Biotech、MicroPharm、CSL
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：多価、一価
・用途別分析2017年-2028年：病院・診療所、非営利団体
・アンチベニンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・アンチベニンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・アンチベニンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・アンチベニンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・アンチベニンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Antivenin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Antivenin market size is estimated to be worth US$ 987 million in 2021 and is forecast to a readjusted size of USD 1293.8 million by 2028 with a CAGR of 3.9% during review period. Hospitals and Clinics accounting for % of the Antivenin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Polyvalent segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Antivenin include CSL, Merck, BTG, Pfizer, and Haffkine Bio-Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antivenin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Polyvalent
Monovalent
Market segment by Application can be divided into
Hospitals and Clinics
Non-profit Institutions
The key market players for global Antivenin market are listed below:
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
CSL
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antivenin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antivenin, with price, sales, revenue and global market share of Antivenin from 2019 to 2022.
Chapter 3, the Antivenin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antivenin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Antivenin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antivenin.
Chapter 13, 14, and 15, to describe Antivenin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Antivenin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antivenin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Polyvalent
1.2.3 Monovalent
1.3 Market Analysis by Application
1.3.1 Overview: Global Antivenin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals and Clinics
1.3.3 Non-profit Institutions
1.4 Global Antivenin Market Size & Forecast
1.4.1 Global Antivenin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Antivenin Sales in Volume (2017-2028)
1.4.3 Global Antivenin Price (2017-2028)
1.5 Global Antivenin Production Capacity Analysis
1.5.1 Global Antivenin Total Production Capacity (2017-2028)
1.5.2 Global Antivenin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antivenin Market Drivers
1.6.2 Antivenin Market Restraints
1.6.3 Antivenin Trends Analysis
2 Manufacturers Profiles
2.1 CSL
2.1.1 CSL Details
2.1.2 CSL Major Business
2.1.3 CSL Antivenin Product and Services
2.1.4 CSL Antivenin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Antivenin Product and Services
2.2.4 Merck Antivenin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 BTG
2.3.1 BTG Details
2.3.2 BTG Major Business
2.3.3 BTG Antivenin Product and Services
2.3.4 BTG Antivenin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Antivenin Product and Services
2.4.4 Pfizer Antivenin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Haffkine Bio-Pharmaceutical
2.5.1 Haffkine Bio-Pharmaceutical Details
2.5.2 Haffkine Bio-Pharmaceutical Major Business
2.5.3 Haffkine Bio-Pharmaceutical Antivenin Product and Services
2.5.4 Haffkine Bio-Pharmaceutical Antivenin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Rare Disease Therapeutics
2.6.1 Rare Disease Therapeutics Details
2.6.2 Rare Disease Therapeutics Major Business
2.6.3 Rare Disease Therapeutics Antivenin Product and Services
2.6.4 Rare Disease Therapeutics Antivenin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Flynn Pharma
2.7.1 Flynn Pharma Details
2.7.2 Flynn Pharma Major Business
2.7.3 Flynn Pharma Antivenin Product and Services
2.7.4 Flynn Pharma Antivenin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Vins Bioproducts
2.8.1 Vins Bioproducts Details
2.8.2 Vins Bioproducts Major Business
2.8.3 Vins Bioproducts Antivenin Product and Services
2.8.4 Vins Bioproducts Antivenin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Bharat Serums and Vaccines
2.9.1 Bharat Serums and Vaccines Details
2.9.2 Bharat Serums and Vaccines Major Business
2.9.3 Bharat Serums and Vaccines Antivenin Product and Services
2.9.4 Bharat Serums and Vaccines Antivenin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Serum Biotech
2.10.1 Serum Biotech Details
2.10.2 Serum Biotech Major Business
2.10.3 Serum Biotech Antivenin Product and Services
2.10.4 Serum Biotech Antivenin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 MicroPharm
2.11.1 MicroPharm Details
2.11.2 MicroPharm Major Business
2.11.3 MicroPharm Antivenin Product and Services
2.11.4 MicroPharm Antivenin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 CSL
2.12.1 CSL Details
2.12.2 CSL Major Business
2.12.3 CSL Antivenin Product and Services
2.12.4 CSL Antivenin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Antivenin Breakdown Data by Manufacturer
3.1 Global Antivenin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Antivenin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Antivenin
3.4 Market Concentration Rate
3.4.1 Top 3 Antivenin Manufacturer Market Share in 2021
3.4.2 Top 6 Antivenin Manufacturer Market Share in 2021
3.5 Global Antivenin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Antivenin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antivenin Market Size by Region
4.1.1 Global Antivenin Sales in Volume by Region (2017-2028)
4.1.2 Global Antivenin Revenue by Region (2017-2028)
4.2 North America Antivenin Revenue (2017-2028)
4.3 Europe Antivenin Revenue (2017-2028)
4.4 Asia-Pacific Antivenin Revenue (2017-2028)
4.5 South America Antivenin Revenue (2017-2028)
4.6 Middle East and Africa Antivenin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Antivenin Sales in Volume by Type (2017-2028)
5.2 Global Antivenin Revenue by Type (2017-2028)
5.3 Global Antivenin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Antivenin Sales in Volume by Application (2017-2028)
6.2 Global Antivenin Revenue by Application (2017-2028)
6.3 Global Antivenin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Antivenin Sales by Type (2017-2028)
7.2 North America Antivenin Sales by Application (2017-2028)
7.3 North America Antivenin Market Size by Country
7.3.1 North America Antivenin Sales in Volume by Country (2017-2028)
7.3.2 North America Antivenin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Antivenin Sales by Type (2017-2028)
8.2 Europe Antivenin Sales by Application (2017-2028)
8.3 Europe Antivenin Market Size by Country
8.3.1 Europe Antivenin Sales in Volume by Country (2017-2028)
8.3.2 Europe Antivenin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Antivenin Sales by Type (2017-2028)
9.2 Asia-Pacific Antivenin Sales by Application (2017-2028)
9.3 Asia-Pacific Antivenin Market Size by Region
9.3.1 Asia-Pacific Antivenin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Antivenin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Antivenin Sales by Type (2017-2028)
10.2 South America Antivenin Sales by Application (2017-2028)
10.3 South America Antivenin Market Size by Country
10.3.1 South America Antivenin Sales in Volume by Country (2017-2028)
10.3.2 South America Antivenin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antivenin Sales by Type (2017-2028)
11.2 Middle East & Africa Antivenin Sales by Application (2017-2028)
11.3 Middle East & Africa Antivenin Market Size by Country
11.3.1 Middle East & Africa Antivenin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Antivenin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Antivenin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Antivenin
12.3 Antivenin Production Process
12.4 Antivenin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Antivenin Typical Distributors
13.3 Antivenin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Antivenin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Antivenin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. CSL Basic Information, Manufacturing Base and Competitors
Table 4. CSL Major Business
Table 5. CSL Antivenin Product and Services
Table 6. CSL Antivenin Sales (K Vials), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Antivenin Product and Services
Table 10. Merck Antivenin Sales (K Vials), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. BTG Basic Information, Manufacturing Base and Competitors
Table 12. BTG Major Business
Table 13. BTG Antivenin Product and Services
Table 14. BTG Antivenin Sales (K Vials), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Antivenin Product and Services
Table 18. Pfizer Antivenin Sales (K Vials), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Haffkine Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Haffkine Bio-Pharmaceutical Major Business
Table 21. Haffkine Bio-Pharmaceutical Antivenin Product and Services
Table 22. Haffkine Bio-Pharmaceutical Antivenin Sales (K Vials), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Rare Disease Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Rare Disease Therapeutics Major Business
Table 25. Rare Disease Therapeutics Antivenin Product and Services
Table 26. Rare Disease Therapeutics Antivenin Sales (K Vials), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Flynn Pharma Basic Information, Manufacturing Base and Competitors
Table 28. Flynn Pharma Major Business
Table 29. Flynn Pharma Antivenin Product and Services
Table 30. Flynn Pharma Antivenin Sales (K Vials), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Vins Bioproducts Basic Information, Manufacturing Base and Competitors
Table 32. Vins Bioproducts Major Business
Table 33. Vins Bioproducts Antivenin Product and Services
Table 34. Vins Bioproducts Antivenin Sales (K Vials), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Bharat Serums and Vaccines Basic Information, Manufacturing Base and Competitors
Table 36. Bharat Serums and Vaccines Major Business
Table 37. Bharat Serums and Vaccines Antivenin Product and Services
Table 38. Bharat Serums and Vaccines Antivenin Sales (K Vials), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Serum Biotech Basic Information, Manufacturing Base and Competitors
Table 40. Serum Biotech Major Business
Table 41. Serum Biotech Antivenin Product and Services
Table 42. Serum Biotech Antivenin Sales (K Vials), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. MicroPharm Basic Information, Manufacturing Base and Competitors
Table 44. MicroPharm Major Business
Table 45. MicroPharm Antivenin Product and Services
Table 46. MicroPharm Antivenin Sales (K Vials), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. CSL Basic Information, Manufacturing Base and Competitors
Table 48. CSL Major Business
Table 49. CSL Antivenin Product and Services
Table 50. CSL Antivenin Sales (K Vials), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Antivenin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Vials)
Table 52. Global Antivenin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Antivenin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Antivenin Production Capacity by Company, (K Vials): 2020 VS 2021
Table 55. Head Office and Antivenin Production Site of Key Manufacturer
Table 56. Antivenin New Entrant and Capacity Expansion Plans
Table 57. Antivenin Mergers & Acquisitions in the Past Five Years
Table 58. Global Antivenin Sales by Region (2017-2022) & (K Vials)
Table 59. Global Antivenin Sales by Region (2023-2028) & (K Vials)
Table 60. Global Antivenin Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Antivenin Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Antivenin Sales by Type (2017-2022) & (K Vials)
Table 63. Global Antivenin Sales by Type (2023-2028) & (K Vials)
Table 64. Global Antivenin Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Antivenin Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Antivenin Price by Type (2017-2022) & (USD/Vial)
Table 67. Global Antivenin Price by Type (2023-2028) & (USD/Vial)
Table 68. Global Antivenin Sales by Application (2017-2022) & (K Vials)
Table 69. Global Antivenin Sales by Application (2023-2028) & (K Vials)
Table 70. Global Antivenin Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Antivenin Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Antivenin Price by Application (2017-2022) & (USD/Vial)
Table 73. Global Antivenin Price by Application (2023-2028) & (USD/Vial)
Table 74. North America Antivenin Sales by Country (2017-2022) & (K Vials)
Table 75. North America Antivenin Sales by Country (2023-2028) & (K Vials)
Table 76. North America Antivenin Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Antivenin Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Antivenin Sales by Type (2017-2022) & (K Vials)
Table 79. North America Antivenin Sales by Type (2023-2028) & (K Vials)
Table 80. North America Antivenin Sales by Application (2017-2022) & (K Vials)
Table 81. North America Antivenin Sales by Application (2023-2028) & (K Vials)
Table 82. Europe Antivenin Sales by Country (2017-2022) & (K Vials)
Table 83. Europe Antivenin Sales by Country (2023-2028) & (K Vials)
Table 84. Europe Antivenin Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Antivenin Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Antivenin Sales by Type (2017-2022) & (K Vials)
Table 87. Europe Antivenin Sales by Type (2023-2028) & (K Vials)
Table 88. Europe Antivenin Sales by Application (2017-2022) & (K Vials)
Table 89. Europe Antivenin Sales by Application (2023-2028) & (K Vials)
Table 90. Asia-Pacific Antivenin Sales by Region (2017-2022) & (K Vials)
Table 91. Asia-Pacific Antivenin Sales by Region (2023-2028) & (K Vials)
Table 92. Asia-Pacific Antivenin Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Antivenin Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Antivenin Sales by Type (2017-2022) & (K Vials)
Table 95. Asia-Pacific Antivenin Sales by Type (2023-2028) & (K Vials)
Table 96. Asia-Pacific Antivenin Sales by Application (2017-2022) & (K Vials)
Table 97. Asia-Pacific Antivenin Sales by Application (2023-2028) & (K Vials)
Table 98. South America Antivenin Sales by Country (2017-2022) & (K Vials)
Table 99. South America Antivenin Sales by Country (2023-2028) & (K Vials)
Table 100. South America Antivenin Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Antivenin Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Antivenin Sales by Type (2017-2022) & (K Vials)
Table 103. South America Antivenin Sales by Type (2023-2028) & (K Vials)
Table 104. South America Antivenin Sales by Application (2017-2022) & (K Vials)
Table 105. South America Antivenin Sales by Application (2023-2028) & (K Vials)
Table 106. Middle East & Africa Antivenin Sales by Region (2017-2022) & (K Vials)
Table 107. Middle East & Africa Antivenin Sales by Region (2023-2028) & (K Vials)
Table 108. Middle East & Africa Antivenin Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Antivenin Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Antivenin Sales by Type (2017-2022) & (K Vials)
Table 111. Middle East & Africa Antivenin Sales by Type (2023-2028) & (K Vials)
Table 112. Middle East & Africa Antivenin Sales by Application (2017-2022) & (K Vials)
Table 113. Middle East & Africa Antivenin Sales by Application (2023-2028) & (K Vials)
Table 114. Antivenin Raw Material
Table 115. Key Manufacturers of Antivenin Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Antivenin Typical Distributors
Table 119. Antivenin Typical Customers
List of Figures
Figure 1. Antivenin Picture
Figure 2. Global Antivenin Revenue Market Share by Type in 2021
Figure 3. Polyvalent
Figure 4. Monovalent
Figure 5. Global Antivenin Revenue Market Share by Application in 2021
Figure 6. Hospitals and Clinics
Figure 7. Non-profit Institutions
Figure 8. Global Antivenin Revenue, (USD Million) & (K Vials): 2017 & 2021 & 2028
Figure 9. Global Antivenin Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Antivenin Sales (2017-2028) & (K Vials)
Figure 11. Global Antivenin Price (2017-2028) & (USD/Vial)
Figure 12. Global Antivenin Production Capacity (2017-2028) & (K Vials)
Figure 13. Global Antivenin Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Antivenin Market Drivers
Figure 15. Antivenin Market Restraints
Figure 16. Antivenin Market Trends
Figure 17. Global Antivenin Sales Market Share by Manufacturer in 2021
Figure 18. Global Antivenin Revenue Market Share by Manufacturer in 2021
Figure 19. Antivenin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Antivenin Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Antivenin Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Antivenin Sales Market Share by Region (2017-2028)
Figure 23. Global Antivenin Revenue Market Share by Region (2017-2028)
Figure 24. North America Antivenin Revenue (2017-2028) & (USD Million)
Figure 25. Europe Antivenin Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Antivenin Revenue (2017-2028) & (USD Million)
Figure 27. South America Antivenin Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Antivenin Revenue (2017-2028) & (USD Million)
Figure 29. Global Antivenin Sales Market Share by Type (2017-2028)
Figure 30. Global Antivenin Revenue Market Share by Type (2017-2028)
Figure 31. Global Antivenin Price by Type (2017-2028) & (USD/Vial)
Figure 32. Global Antivenin Sales Market Share by Application (2017-2028)
Figure 33. Global Antivenin Revenue Market Share by Application (2017-2028)
Figure 34. Global Antivenin Price by Application (2017-2028) & (USD/Vial)
Figure 35. North America Antivenin Sales Market Share by Type (2017-2028)
Figure 36. North America Antivenin Sales Market Share by Application (2017-2028)
Figure 37. North America Antivenin Sales Market Share by Country (2017-2028)
Figure 38. North America Antivenin Revenue Market Share by Country (2017-2028)
Figure 39. United States Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Antivenin Sales Market Share by Type (2017-2028)
Figure 43. Europe Antivenin Sales Market Share by Application (2017-2028)
Figure 44. Europe Antivenin Sales Market Share by Country (2017-2028)
Figure 45. Europe Antivenin Revenue Market Share by Country (2017-2028)
Figure 46. Germany Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Antivenin Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Antivenin Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Antivenin Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Antivenin Revenue Market Share by Region (2017-2028)
Figure 55. China Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Antivenin Sales Market Share by Type (2017-2028)
Figure 62. South America Antivenin Sales Market Share by Application (2017-2028)
Figure 63. South America Antivenin Sales Market Share by Country (2017-2028)
Figure 64. South America Antivenin Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Antivenin Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Antivenin Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Antivenin Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Antivenin Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Antivenin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Antivenin in 2021
Figure 76. Manufacturing Process Analysis of Antivenin
Figure 77. Antivenin Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の三次元電気生理ナビゲーションシステム市場2022年：市場規模予測（～2028年）
  • 世界の血漿分画装置市場2022年：市場規模予測（～2028年）
  • 世界のヒト肝臓モデル市場2022年：市場規模予測（～2028年）
  • 世界のハイブリッド手首固定器市場2022年：市場規模予測（～2028年）
  • 世界の使い捨て型歯科滅菌針市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19155 )"世界のアンチベニン市場2022年：市場規模予測（～2028年）" (英文：Global Antivenin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。